Log in to save to my catalogue

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injur...

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injur...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6355243

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury

About this item

Full title

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2019-02, Vol.129 (2), p.786-801

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Tumor cure with conventional fractionated radiotherapy is 65%, dependent on tumor cell-autonomous gradual buildup of DNA double-strand break (DSB) misrepair. Here we report that single-dose radiotherapy (SDRT), a disruptive technique that ablates more than 90% of human cancers, operates a distinct dual-target mechanism, linking acid sphingomyelinas...

Alternative Titles

Full title

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6355243

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6355243

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI97631

How to access this item